Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.

Jenkins NC, Rao G, Eberhart CG, Pedone CA, Dubuc AM, Fults DW.

J Neurooncol. 2016 Feb;126(3):415-24. doi: 10.1007/s11060-015-1985-9. Epub 2015 Oct 30.

2.

The prenatal origins of cancer.

Marshall GM, Carter DR, Cheung BB, Liu T, Mateos MK, Meyerowitz JG, Weiss WA.

Nat Rev Cancer. 2014 Apr;14(4):277-89. doi: 10.1038/nrc3679. Epub 2014 Mar 6. Review.

3.

The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs).

Rogers HA, Ward JH, Miller S, Lowe J, Coyle B, Grundy RG.

Br J Cancer. 2013 May 28;108(10):2130-41. doi: 10.1038/bjc.2013.170. Epub 2013 Apr 16.

4.

Signals that regulate the oncogenic fate of neural stem cells and progenitors.

Swartling FJ, Bolin S, Phillips JJ, Persson AI.

Exp Neurol. 2014 Oct;260:56-68. doi: 10.1016/j.expneurol.2013.01.027. Epub 2013 Jan 31. Review.

5.

What underlies the diversity of brain tumors?

Swartling FJ, Hede SM, Weiss WA.

Cancer Metastasis Rev. 2013 Jun;32(1-2):5-24. doi: 10.1007/s10555-012-9407-3. Review.

6.

WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma.

Rogers HA, Sousa S, Salto C, Arenas E, Coyle B, Grundy RG.

Br J Cancer. 2012 Sep 25;107(7):1144-52. doi: 10.1038/bjc.2012.377. Epub 2012 Aug 28.

8.

Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.

Künkele A, De Preter K, Heukamp L, Thor T, Pajtler KW, Hartmann W, Mittelbronn M, Grotzer MA, Deubzer HE, Speleman F, Schramm A, Eggert A, Schulte JH.

Neuro Oncol. 2012 Jul;14(7):859-69. doi: 10.1093/neuonc/nos115. Epub 2012 May 16.

9.

Myc proteins in brain tumor development and maintenance.

Swartling FJ.

Ups J Med Sci. 2012 May;117(2):122-31. doi: 10.3109/03009734.2012.658975. Epub 2012 Feb 21.

10.

Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.

Park AK, Lee SJ, Phi JH, Wang KC, Kim DG, Cho BK, Haberler C, Fattet S, Dufour C, Puget S, Sainte-Rose C, Bourdeaut F, Grill J, Delattre O, Kim SK, Park WY.

Neuro Oncol. 2012 Feb;14(2):203-14. doi: 10.1093/neuonc/nor196. Epub 2011 Nov 16.

11.

Pleiotropic role for MYCN in medulloblastoma.

Swartling FJ, Grimmer MR, Hackett CS, Northcott PA, Fan QW, Goldenberg DD, Lau J, Masic S, Nguyen K, Yakovenko S, Zhe XN, Gilmer HC, Collins R, Nagaoka M, Phillips JJ, Jenkins RB, Tihan T, Vandenberg SR, James CD, Tanaka K, Taylor MD, Weiss WA, Chesler L.

Genes Dev. 2010 May 15;24(10):1059-72. doi: 10.1101/gad.1907510.

12.

Wnt signaling in development and disease.

Freese JL, Pino D, Pleasure SJ.

Neurobiol Dis. 2010 May;38(2):148-53. doi: 10.1016/j.nbd.2009.09.003. Epub 2009 Sep 16. Review.

Supplemental Content

Support Center